# Effects of Vitamin D3 and Yeast Beta-Glucan Supplementation on Glycemic Control and Cardiovascular Disease Risk in Patients With Type 2 Diabetes

> **NCT06861062** · NA · RECRUITING · sponsor: **Huazhong University of Science and Technology** · enrollment: 2500 (estimated)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** Vitamin D3
- **DIETARY_SUPPLEMENT:** yeast β-glucan
- **DIETARY_SUPPLEMENT:** Vitamin D placebo
- **DIETARY_SUPPLEMENT:** yeast β-glucan placebo

## Key facts

- **NCT ID:** NCT06861062
- **Lead sponsor:** Huazhong University of Science and Technology
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-04-08
- **Primary completion:** 2030-12-31
- **Final completion:** 2032-12-31
- **Target enrollment:** 2500 (ESTIMATED)
- **Last updated:** 2026-02-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06861062

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06861062, "Effects of Vitamin D3 and Yeast Beta-Glucan Supplementation on Glycemic Control and Cardiovascular Disease Risk in Patients With Type 2 Diabetes". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06861062. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*